Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Building stem-cell genomics in California and beyond

By devoting funding to whole-genome studies, such as epigenetic and copy-number variation in stem cells, research on new genomic technology, and standards for methodologies and data collection/sharing, CIRM can spur both basic and translational research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2: A flow chart depicting major stages of the proposed stem-cell genomics pipeline.
Figure 3

References

  1. National Research Council of the National Academies. Committee on a Framework for Development a New Taxonomy of Disease; National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. (The National Academies Press, Washington, DC, 2011).

  2. Mayshar, Y. et al. Cell Stem Cell 7, 521–531 (2010).

    Article  CAS  Google Scholar 

  3. Gore et al. Nature 47, 63–67 (2011).

    Article  Google Scholar 

  4. Hussein, S.M. et al. Nature 471, 58–62 (2011).

    Article  CAS  Google Scholar 

  5. Subkhankulova, T. et al. BMC Genomics 9, 268 (2008).

    Article  Google Scholar 

  6. Stahlberg, A. et al. Nucleic Acids Res. 39, e24 (2011).

    Article  Google Scholar 

  7. Kalisky, T. & Quake, S. Nat. Methods 8, 311–314 (2011).

    Article  CAS  Google Scholar 

  8. Eldar, A. & Elowitz, M.B. Nature 467, 167–173 (2010).

    Article  CAS  Google Scholar 

  9. Reya, T. et al. Nature 414, 105–111 (2001).

    Article  CAS  Google Scholar 

  10. Bao, S. et al. Nature 444, 756–760 (2006).

    Article  CAS  Google Scholar 

  11. Dean, M. et al. Nat. Rev. Cancer 5, 275–284 (2005).

    Article  CAS  Google Scholar 

  12. Bernstein, B.E. et al. Nat. Biotechnol. 28, 1045–1048 (2010).

    Article  CAS  Google Scholar 

  13. Gerstein, M.B. et al. Genome Res. 17, 669–681 (2007).

    Article  CAS  Google Scholar 

  14. Lu, R. et al. Nature 462, 358–362 (2009).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the many scientists with whom we have had illuminating discussions essential to formulating this article, as well as colleagues at CIRM.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Natalie D DeWitt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DeWitt, N., Yaffe, M. & Trounson, A. Building stem-cell genomics in California and beyond. Nat Biotechnol 30, 20–25 (2012). https://doi.org/10.1038/nbt.2086

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2086

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research